En Es
Categories

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic testing for organisms and genetic-based diseases
Products Covid-19Summary
Close

Covid-19 CEPHEID

Clinical Laboratory

SARS-CoV-2 Test
Xpert® Xpress SARS-CoV-2

The Xpert® Xpress SARS-CoV-2 is a rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19 that leverages the design principles of Cepheid’s current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in as soon as 30 minutes for positive results with less than a minute of hands on time to prepare the sample.
More details

SARS-CoV-2/Flu/RSV Test
Xpert® Xpress SARS-CoV-2/Flu/RSV

The Xpert® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. The test is designed for use on any of Cepheid's more than 25,000 GeneXpert® Systems placed worldwide, with results expected in as little as 35 minutes.
More details
Close

About CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic testing for organisms and genetic-based diseases
FaceBook Twitter Google+ Linked in
Molecular Diagnostic System

Molecular Diagnostic System

Model: Xpert MRSA/SA BC
Request Information

Description:

The Xpert MRSA/SA BC can carry out accurate molecular detection of MRSA or SA from a gram-positive blood culture sample in about an hour. Its simple test protocol can be run on all shifts to provide results around-the-clock and provides clinicians actionable information when it is most needed.


Send A Message To This Supplier

* Required Information
* Email
To
CEPHEID (Molecular Diagnostic System)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions